Pfizer’s Paxlovid fails as 15-day treatment for long COVID, study finds
By Michael Erman (Reuters) – A 15-day course of Pfizer’s COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven treatments specifically for long COVID in which a host of symptoms can last for many months after initial coronavirus infection. Scientists and…